Author

O. Zimhony

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:proteomics· 3 Organism:human· 2 Research Focus:cell type annotation· 1 Organism:E. coli· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

A. Clark· 1 shared A. F. Carlin· 1 shared A. Mechaly· 1 shared A. Roitburd-Berman· 1 shared A. Schwartz· 1 shared A. Tennenhouse· 1 shared A. Zvi· 1 shared B. A. Croker· 1 shared

Activity by Year

2018-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Clark

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologyCell ReportsPeer-reviewedSep 1, 2021

The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against novel viral variants

E. Makdasi, A. Zvi, R. Alcalay…·R. Rosenfeld

This study evaluates the neutralization potency of four SARS-CoV-2 mAbs against spike mutations and two variants of concern, finding that MD65 and BL6 retain effectiveness against B.1.1.7 and B.1.351.

DOI 10.1016/j.celrep.2021.109679

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivOct 6, 2020

Multi-Clonal Live SARS-CoV-2 In Vitro Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors

M. Mor, M. Werbner, J. Alter…·N. Freund

This study identifies multi-clonal neutralizing antibodies against SARS-CoV-2 in severe COVID-19 patients and shows their potential for combination therapy.

DOI 10.1371/journal.ppat.1009165

humanproteomics

𝕏 PostBluesky

MicrobiologybioRxivAug 28, 2018

Expression of a recombinant, 4’-Phosphopantetheinylated, active M. tuberculosis Fatty acid Synthase I in E. coli

S. Baron, Y. Peleg, J. Grunwald…·O. Zimhony

This paper describes the expression and activation of Mtb FAS I in E. coli using AcpS, confirming its biochemical activity and structural properties.

DOI 10.1371/journal.pone.0204457

E. coliproteomics

𝕏 PostBluesky